This playbook explores key trends, consumer insights, and formulation strategies shaping the future of food and beverage in the GLP-1 era, helping you meet the needs of a fast-growing consumer segment.

Consumers across all demographics are rethinking their relationship with food, and GLP-1 medications are accelerating this shift. Appetite suppression, smaller portions, and a focus on nutrient density are transforming grocery carts and creating new opportunities for brands.

Today’s consumers are actively seeking products that deliver satiety, functional benefits, and indulgence - all while aligning with goals like weight management and gut health.

With 15 million Americans already using GLP-1 medications and usage expected to double in the next decade, now is the time to innovate. Whether you are reformulating snacks, beverages, or indulgent treats, it's crucial to understand what drives purchasing decisions in this new landscape.

In this playbook, you’ll glean insights from Tate & Lyle’s proprietary nutrition and consumer research, and learn from our experts about the changes, challenges, and opportunities CPG manufacturers face when formulating in the GLP-1 era. You’ll discover:

• Key trends in grocery spending and ingredient preferences driven by the GLP-1 movement
  
• Proprietary insights into the evolving needs and motivations of GLP-1 users, former users, and non-users
• Real-world examples and expert guidance to help you innovate and lead in the better-for-you marketplace
  

Offered Free by: Food Dive's studioID and Tate & Lyle